Lithium exposure causes ferroptosis to induce unexplained miscarriage through non-canonical MBOAT1 pathway
Yes semaglutide (Wegovy) and liraglutide (Saxenda) are licensed GLP-1 receptor agonist medicines available through NHS specialist weight management services for eligible patients, in line with NICE TA875 and NICE TA664 respectively
It is helpful in preventing fatigue and may also be useful in some cases of allergies because it reduces histamine release
The triple-receptor action (GLP-1, GIP, glucagon) is the reason it outperforms semaglutide and tirzepatide
Really happy with the results so far
The most common side effects are injection-site soreness (41%, lasting 24-36 hours), mild nausea (12-15%, lasting 4-8 hours), and skin flushing (8-10%, lasting 10-30 minutes)